Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille‐Box, Amandine Alard, Molykutty J. Aryankalayil, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 1436

Showing 1-25 of 1436 citing articles:

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi, Ilio Vitale, Stuart A. Aaronson, et al.
Cell Death and Differentiation (2018) Vol. 25, Iss. 3, pp. 486-541
Open Access | Times Cited: 5295
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek, Francisco J. Cueto, Adriana M. Mujal, et al.
Nature reviews. Immunology (2019) Vol. 20, Iss. 1, pp. 7-24
Closed Access | Times Cited: 1973
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni, Helen K. Angell, Jérôme Galon
Nature reviews. Cancer (2020) Vol. 20, Iss. 11, pp. 662-680
Closed Access | Times Cited: 1199
Mitochondrial metabolism and cancer
Paolo E. Porporato, Nicoletta Filigheddu, José Manuel Bravo‐San Pedro, et al.
Cell Research (2017) Vol. 28, Iss. 3, pp. 265-280
Open Access | Times Cited: 1047
Using immunotherapy to boost the abscopal effect
Wilfred Ngwa, Omoruyi Credit Irabor, Jonathan D. Schoenfeld, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 5, pp. 313-322
Open Access | Times Cited: 997
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 12, pp. 725-741
Closed Access | Times Cited: 992
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000337-e000337
Open Access | Times Cited: 838
Immunogenic cell stress and death
Guido Kroemer, Claudia Galassi, Laurence Zitvogel, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 487-500
Open Access | Times Cited: 834
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
Xueting Lang, Michael D. Green, Weimin Wang, et al.
Cancer Discovery (2019) Vol. 9, Iss. 12, pp. 1673-1685
Open Access | Times Cited: 793
Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer
Willemijn S.M.E. Theelen, Heike Peulen, Ferry Lalezari, et al.
JAMA Oncology (2019) Vol. 5, Iss. 9, pp. 1276-1276
Open Access | Times Cited: 778
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Silvia C. Formenti, Nils-Petter Rudqvist, Encouse B. Golden, et al.
Nature Medicine (2018) Vol. 24, Iss. 12, pp. 1845-1851
Open Access | Times Cited: 756
Harnessing innate immunity in cancer therapy
Olivier Demaria, Stéphanie Cornen, Marc Daëron, et al.
Nature (2019) Vol. 574, Iss. 7776, pp. 45-56
Closed Access | Times Cited: 751
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng, Wen Jiang, Betty Y.S. Kim, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 568-586
Open Access | Times Cited: 744
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings, et al.
Nature Medicine (2019) Vol. 25, Iss. 6, pp. 920-928
Closed Access | Times Cited: 737
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 734
Enhancing cancer immunotherapy with nanomedicine
Darrell J. Irvine, Eric L. Dane
Nature reviews. Immunology (2020) Vol. 20, Iss. 5, pp. 321-334
Open Access | Times Cited: 670
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Jiali Yu, Michael D. Green, Shasha Li, et al.
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 152-164
Open Access | Times Cited: 665
Control of Metastasis by NK Cells
Alejandro López‐Soto, Segundo González, Mark J. Smyth, et al.
Cancer Cell (2017) Vol. 32, Iss. 2, pp. 135-154
Open Access | Times Cited: 645
Radiotherapy toxicity
Dirk De Ruysscher, Gabriele Niedermann, N.G. Burnet, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 644
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Martin McLaughlin, Emmanuel C. Patin, Malin Pedersen, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 203-217
Closed Access | Times Cited: 609
Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Qian Chen, Jiawen Chen, Zhijuan Yang, et al.
Advanced Materials (2019) Vol. 31, Iss. 10
Closed Access | Times Cited: 594
The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment
Samuel F. Bakhoum, Lewis C. Cantley
Cell (2018) Vol. 174, Iss. 6, pp. 1347-1360
Open Access | Times Cited: 564
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
John D. Martin, Horacio Cabral, Triantafyllos Stylianopoulos, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 4, pp. 251-266
Open Access | Times Cited: 537
Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
Shetal Patel, Andy J. Minn
Immunity (2018) Vol. 48, Iss. 3, pp. 417-433
Open Access | Times Cited: 492
The hallmarks of successful anticancer immunotherapy
Lorenzo Galluzzi, Timothy A. Chan, Guido Kroemer, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 459
Open Access | Times Cited: 491
Page 1 - Next Page

Scroll to top